|
MechanismNF-κB inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.- |
First Approval Date01 Jan 1972 |
100 Clinical Results associated with ASAC Pharmaceutical Internacional AIE
0 Patents (Medical) associated with ASAC Pharmaceutical Internacional AIE
100 Deals associated with ASAC Pharmaceutical Internacional AIE
100 Translational Medicine associated with ASAC Pharmaceutical Internacional AIE